Assessing causality by means of the Naranjo scale in a paediatric patient with life threatening respiratory failure after alemtuzumab administration: a case report

BACKGROUND: Alemtuzumab is a T cell depleting antibody agent used as induction immunosuppressant therapy in solid organ transplant recipients. In addition, it is being increasingly used to treat severe or glucocorticoid-resistant graft rejection. Despite the effectiveness of the treatment, severe ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Smeets, Nori J. L., Eijk, Ruud J. R., de Wildt, Saskia N., Bootsma-Robroeks, Charlotte M. H. H. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113285/
https://www.ncbi.nlm.nih.gov/pubmed/33980211
http://dx.doi.org/10.1186/s12887-021-02698-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113285/
https://www.ncbi.nlm.nih.gov/pubmed/33980211
http://dx.doi.org/10.1186/s12887-021-02698-w

Ejemplares similares